feed,title,long_url,short_url
Investors,Agios Crashes 19% After A Surprise Side Effect Hammered Its 'Very Safe' Drug,https://www.investors.com/news/technology/agios-pharmaceuticals-stock-thalassemia-treatment-mitapivat/,https://da.gd/JEWhLT
